EVIO, Inc. (EVIO) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
$'dan işlem gören EVIO, Inc. (EVIO), 0 değerindeki bir Healthcare şirketidir. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 47/100 (ihtiyatlı) olarak derecelendirilmiştir.
Son analiz: 17 Mar 2026EVIO, Inc. (EVIO) Sağlık ve Boru Hattı Genel Bakışı
EVIO, Inc. provides analytical testing and advisory services to the U.S. cannabis industry, offering consulting, product formulation, and comprehensive testing services. With a focus on cannabinoid potency, pesticide screening, and regulatory compliance, EVIO supports cannabis businesses in navigating the complex landscape of the evolving market.
Yatırım Tezi
EVIO, Inc. presents a focused play on the cannabis testing and advisory services market. With a P/E ratio of 3.34 and a gross margin of 33.0%, the company demonstrates potential profitability. Growth catalysts include the expansion of cannabis legalization across states, driving demand for testing and compliance services. Key risks include intense competition and the evolving regulatory landscape. Investors should monitor revenue growth, profitability improvements, and the company's ability to adapt to changing regulations in the cannabis industry. The company's beta of 81.01 indicates high volatility.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- EVIO, Inc. operates in the cannabis analytical testing and advisory services market within the United States.
- The company's profit margin is 3.0%, indicating a potential for improvement in operational efficiency.
- EVIO's gross margin stands at 33.0%, reflecting its ability to manage the cost of services effectively.
- The company's P/E ratio is 3.34, suggesting it may be undervalued compared to its earnings.
- EVIO's beta is 81.01, indicating high volatility compared to the market.
Rakipler & Benzerleri
Güçlü Yönler
- Comprehensive suite of testing and advisory services.
- Expertise in cannabis testing and compliance.
- Established relationships with cannabis businesses.
- Reputation for accuracy and reliability.
Zayıflıklar
- Small size and limited resources.
- Dependence on the cannabis industry.
- Limited geographic reach.
- High beta indicating high volatility.
Katalizörler
- Upcoming: Expansion into new states legalizing cannabis, increasing demand for testing services.
- Ongoing: Increasing regulatory scrutiny in the cannabis industry, driving demand for compliance services.
- Ongoing: Strategic partnerships with cannabis cultivators, processors, and retailers.
Riskler
- Potential: Intense competition from other testing labs and consulting firms.
- Potential: Evolving regulatory landscape and potential changes in cannabis laws.
- Potential: Economic downturn affecting the cannabis industry.
- Ongoing: Limited financial disclosure due to OTC listing.
- Ongoing: Low trading volume and liquidity on the OTC market.
Büyüme Fırsatları
- Expansion into New Geographies: As more states legalize cannabis, EVIO has the opportunity to expand its testing and advisory services into these new markets. This geographic expansion can significantly increase its revenue base. The timeline for this growth is dependent on the pace of legalization in different states, but it represents a substantial long-term growth opportunity. By establishing testing facilities and building relationships with local cannabis businesses, EVIO can capitalize on the growing demand for its services.
- Development of New Testing Services: EVIO can expand its service offerings to include more specialized testing services, such as heavy metal analysis or genetic testing of cannabis strains. These new services can attract a wider range of customers and increase revenue per client. The timeline for developing these services depends on the availability of technology and expertise, but it represents a valuable opportunity to differentiate EVIO from its competitors. This diversification can enhance EVIO's competitive advantage and market position.
- Strategic Partnerships: Forming strategic partnerships with cannabis cultivators, processors, and retailers can provide EVIO with a steady stream of clients and revenue. These partnerships can also help EVIO expand its geographic reach and service offerings. The timeline for establishing these partnerships depends on the company's ability to build relationships and negotiate favorable terms. However, these partnerships can provide a significant boost to EVIO's growth and profitability.
- Increased Regulatory Scrutiny: As the cannabis industry matures, regulatory scrutiny is likely to increase, driving demand for EVIO's compliance and testing services. This trend presents a significant growth opportunity for the company. The timeline for this growth is dependent on the actions of regulatory bodies, but it is likely to be a long-term trend. By staying ahead of the curve and offering comprehensive compliance solutions, EVIO can position itself as a trusted partner for cannabis businesses.
- Product Formulation and Advisory Services: EVIO can leverage its expertise in cannabis testing to offer product formulation and advisory services to cannabis businesses. This can help these businesses develop new and innovative products that meet regulatory requirements and consumer demand. The timeline for this growth depends on the company's ability to attract and retain talented scientists and consultants, but it represents a valuable opportunity to expand its service offerings and increase revenue.
Fırsatlar
- Expansion into new geographic markets.
- Development of new testing services.
- Strategic partnerships with cannabis businesses.
- Increased regulatory scrutiny driving demand for compliance services.
Tehditler
- Intense competition from other testing labs and consulting firms.
- Evolving regulatory landscape.
- Potential for changes in cannabis laws.
- Economic downturn affecting the cannabis industry.
Rekabet Avantajları
- Specialized expertise in cannabis testing and compliance.
- Established relationships with cannabis businesses.
- Comprehensive suite of testing and advisory services.
- Reputation for accuracy and reliability.
EVIO Hakkında
EVIO, Inc. was established to provide analytical testing and advisory services to businesses operating within the burgeoning cannabis industry in the United States. Recognizing the need for standardized testing and regulatory compliance in this rapidly evolving market, EVIO has positioned itself as a key service provider for cannabis cultivators, processors, and retailers. The company offers a comprehensive suite of services, including consulting, product formulation, and licensing and compliance assistance. Its analytical testing services encompass cannabinoid potency testing, terpene analysis, pesticide testing, residual solvent screening, visual inspections, and biological contaminant testing. These services are designed to ensure product safety, quality, and compliance with state and local regulations. Headquartered in Henderson, Nevada, EVIO, Inc. aims to support the growth and legitimacy of the cannabis industry by providing reliable and accurate testing and advisory solutions.
Ne Yaparlar
- Provides analytical testing services to the cannabis industry.
- Offers consulting services related to cannabis product formulation.
- Assists cannabis businesses with licensing and compliance.
- Conducts cannabinoid potency testing.
- Performs terpene analysis.
- Screens for pesticides and residual solvents.
- Conducts visual inspections of cannabis products.
- Tests for biological contaminants.
İş Modeli
- Generates revenue through analytical testing services for cannabis products.
- Earns fees from consulting services related to product formulation and regulatory compliance.
- Partnerships with cannabis cultivators, processors, and retailers.
- Offers specialized testing services, such as heavy metal analysis and genetic testing.
Sektör Bağlamı
EVIO, Inc. operates within the rapidly expanding cannabis industry, which is experiencing significant growth due to increasing legalization and acceptance across the United States. The market for cannabis testing and advisory services is becoming increasingly important as regulations tighten and consumers demand safer, more reliable products. Competition is intensifying, with numerous testing labs and consulting firms vying for market share. EVIO's success depends on its ability to maintain high standards of accuracy, compliance, and customer service in this dynamic environment.
Kilit Müşteriler
- Cannabis cultivators
- Cannabis processors
- Cannabis retailers
- Cannabis product manufacturers
Finansallar
Grafik & Bilgi
EVIO, Inc. (EVIO) hisse senedi fiyatı: Price data unavailable
Son Haberler
-
Stocks That Hit 52-Week Lows On Friday
· 6 Ara 2019
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
EVIO için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
EVIO için Wall Street fiyat hedefi analizi.
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, EVIO'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
Rakipler & Benzerleri
Yönetim: Lori Jean Glauser
CEO
Lori Jean Glauser serves as the CEO of EVIO, Inc. Her background includes experience in managing and growing businesses, with a focus on strategic planning and execution. She has demonstrated leadership in navigating complex regulatory environments and building strong teams. Her expertise is crucial for guiding EVIO through the evolving cannabis industry landscape. She is responsible for overseeing all aspects of the company's operations and driving its growth strategy.
Sicil: Under Lori Jean Glauser's leadership, EVIO, Inc. has focused on expanding its testing and advisory services to meet the growing demand in the cannabis industry. She has overseen the development of new testing capabilities and the expansion of the company's geographic reach. Her strategic decisions have aimed to position EVIO as a trusted partner for cannabis businesses seeking to ensure product safety and regulatory compliance. She manages 18 employees.
EVIO OTC Piyasa Bilgileri
The OTC Other tier represents the lowest tier of the OTC market, indicating that EVIO, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial information available to the public, and trading activity may be sporadic. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and regulatory oversight compared to exchanges like the NYSE or NASDAQ.
- OTC Katmanı: OTC Other
- Açıklama Durumu: Unknown
- Limited financial disclosure
- Low trading volume and liquidity
- Higher price volatility
- Potential for fraud or manipulation
- Lack of regulatory oversight
- Verify the company's financial statements.
- Research the company's management team and their track record.
- Assess the company's competitive position in the cannabis testing market.
- Review the company's regulatory filings and compliance history.
- Evaluate the company's growth prospects and expansion plans.
- Monitor trading volume and price volatility.
- Consult with a qualified financial advisor.
- Operational testing facilities and advisory services.
- Partnerships with established cannabis businesses.
- Compliance with state and local regulations.
- Positive customer reviews and testimonials.
- Experienced management team.
Yatırımcılar EVIO, Inc. (EVIO) Hakkında Ne Soruyor
EVIO için değerlendirilmesi gereken temel faktörler nelerdir?
EVIO, Inc. (EVIO) şu anda yapay zeka skoru 47/100, düşük puanı gösteriyor. Temel güçlü yan: Comprehensive suite of testing and advisory services.. İzlenmesi gereken birincil risk: Potential: Intense competition from other testing labs and consulting firms.. Bu bir finansal tavsiye değildir.
EVIO MoonshotScore'u nedir?
EVIO şu anda MoonshotScore'da 47/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
EVIO verileri ne sıklıkla güncellenir?
EVIO fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler EVIO hakkında ne diyor?
EVIO için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.
EVIO'a yatırım yapmanın riskleri nelerdir?
EVIO için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Intense competition from other testing labs and consulting firms.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
EVIO'ın P/E oranı nedir?
EVIO için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için EVIO'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.
EVIO aşırı değerli mi, yoksa düşük değerli mi?
EVIO, Inc. (EVIO)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
EVIO'ın temettü verimi nedir?
EVIO, Inc. (EVIO) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- Limited information available due to OTC listing.
- AI analysis pending for EVIO.